Dissemination (Meeting Coverage)

Take a look at the schedule for AAN Fall Conference. And follow along at PW for conference coverage.

Take a look at some of the fun facts about AAN Fall Conference. And follow PW for conference coverage.

For a retrospective study involving 607 oncology patients treated from 2014-2019, the potential for predicting patient prognosis and guiding immunotherapy treatment through the analysis of total tumor volume (TTV) and artificial intelligence (AI) tumor heterogeneity from CT scans was investigated.

In early-stage non-small cell lung cancer (NSCLC), the recommended treatment options include targeted and immune therapies.

In the management of early-stage non-small cell lung cancer (eNSCLC), the introduction of PD-1/PD-L1 checkpoint inhibitors has marked a significant advancement.

Cancer-associated fibroblasts (CAFs) constitute a critical element of the tumor microenvironment, and TGFβ-induced CAFs have been implicated in poor prognosis across various indications.

One of ESMO’s most popular track is its Young Oncologist Track designed and initiated by the ESMO Young Oncologist Committee.

There are more than 50 satellite symposia sessions taking place at ESMO. Follow PW for conference coverage.

Take a look at ESMO’s keynote sessions and full schedule. Follow PW for conference coverage.

Fall Clinical Dermatology Conference is providing a free live stream for some of the sessions. The live stream allows doctors who are not able to attend in person.

Find the list of Fall Clinical Dermatology Conference’s learning objectives, and follow along for PW coverage.

Take a look at the agenda for Fall Clinical Dermatology Conference. And follow along at PW for conference coverage.

Among patients with diabetic macular edema (DME) and neovascular age-related macular degeneration...

“Jennifer Pinal, a co-author on this study and a current Latinx medical student from the community...

Compared with 2 mg, aflibercept 8 mg administered at varying intervals was more effective, with...

Researchers have found a biomarker to detect early diabetic retinopathy, which involves evaluating...

The objective of the Phase 3 PULSAR trial was to assess the efficacy and safety of intravitreal...